Myozyme Європейський Союз - англійська - EMA (European Medicines Agency)

myozyme

sanofi b.v. - alglucosidase alfa - glycogen storage disease type ii - other alimentary tract and metabolism products, - myozyme is indicated for long-term enzyme-replacement therapy (ert) in patients with a confirmed diagnosis of pompe disease (acid-α-glucosidase deficiency).in patients with late-onset pompe disease the evidence of efficacy is limited.

NORADRENALINE (TARTRATE) AGUETTANT 2mg/ml (SULFITES FREE), concentrate for sol for infusion (4ml) Мальта - англійська - Medicines Authority

noradrenaline (tartrate) aguettant 2mg/ml (sulfites free), concentrate for sol for infusion (4ml)

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - norepinephrine - concentrate for solution for infusion - norepinephrine 2 mg/ml - cardiac therapy

Uromitexan 100mg/ml Solution for Injection or infusion (4ml ampoule) Мальта - англійська - Medicines Authority

uromitexan 100mg/ml solution for injection or infusion (4ml ampoule)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mesna - solution for infusion or injection - mesna 100 mg/ml - all other therapeutic products

Uromitexan 100mg/ml Solution for Injection or infusion (10ml ampoule) Мальта - англійська - Medicines Authority

uromitexan 100mg/ml solution for injection or infusion (10ml ampoule)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mesna - solution for infusion or injection - mesna 100 mg/ml - all other therapeutic products

NORADRENALINE (TARTRATE) AGUETTANT 2mg/ml (SULFITES FREE), concentrate for sol for infusion (8ml) Мальта - англійська - Medicines Authority

noradrenaline (tartrate) aguettant 2mg/ml (sulfites free), concentrate for sol for infusion (8ml)

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - noradrenaline acid, tartrate - concentrate for solution for infusion - noradrenaline acid tartrate 2 mg/ml - cardiac therapy

PHEBRA GLUCOSE 50% intravenous infusion 25g/50mL vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

phebra glucose 50% intravenous infusion 25g/50ml vial

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.